Insight Molecular Diagnostics Inc. (IMDX) Capital expenditures 2016–2025
Insight Molecular Diagnostics Inc. (IMDX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$3.2MFY2025 · since FY2016: $106,000 → $3.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.2M | +517.2% |
| FY2024 | $516,000 | +83.6% |
| FY2023 | $281,000 | -93.5% |
| FY2022 | $4.3M | +93.1% |
| FY2021 | $2.2M | +83.1% |
| FY2020 | $1.2M | +33.7% |
| FY2019 | $918,000 | +2861.3% |
| FY2018 | $31,000 | -65.9% |
| FY2017 | $91,000 | -14.2% |
| FY2016 | $106,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice